Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Metastatic Gastric Adenocarcinoma
×
Ramucirumab
×
Gastrointestinal
×
Clear all
Filters
3
NCT02314117
2021-08-26
RAINFALL
Eli Lilly and Company
Phase 3
Completed
645 enrolled
22 charts